home / stock / rnugf / rnugf short
Short Information | ReNeuron Group (OTCMKTS:RNUGF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 37,022 |
Total Actual Volume | 41,048 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 18 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,851 |
Average Short Percentage | 86.76% |
Is there a RNUGF Short Squeeze or Breakout about to happen?
See the RNUGF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-07-2023 | $0.0515 | $0.0515 | $0.0515 | $0.0515 | 600 | 600 | 100% |
12-01-2023 | $0.039 | $0.039 | $0.039 | $0.039 | 3,000 | 3,000 | 100% |
03-13-2023 | $0 | $0.1225 | $0 | $0 | 7,873 | 7,873 | 100% |
12-22-2022 | $0.1 | $0.1 | $0.1 | $0.1 | 8,500 | 8,500 | 100% |
06-24-2022 | $0.3575 | $0.3575 | $0.3575 | $0.3575 | 899 | 899 | 100% |
05-23-2022 | $0.4525 | $0.4525 | $0.4525 | $0.4525 | 1,925 | 1,925 | 100% |
03-14-2022 | $0.384 | $0.384 | $0.384 | $0.384 | 100 | 100 | 100% |
02-09-2022 | $0.525 | $0.525 | $0.525 | $0.525 | 3,600 | 3,600 | 100% |
01-18-2022 | $0.66 | $0.61 | $0.66 | $0.6 | 4,600 | 3,500 | 76.09% |
01-04-2022 | $1.06 | $1.06 | $1.06 | $1.06 | 950 | 850 | 89.47% |
11-29-2021 | $1.328 | $1.328 | $1.328 | $1.328 | 100 | 100 | 100% |
11-15-2021 | $1.4 | $1.4 | $1.4 | $1.4 | 1,100 | 200 | 18.18% |
04-14-2021 | $1.945 | $1.945 | $1.945 | $1.945 | 200 | 200 | 100% |
04-12-2021 | $1.955 | $1.955 | $1.955 | $1.955 | 100 | 100 | 100% |
04-08-2021 | $1.6 | $1.72 | $1.72 | $1.48 | 1,400 | 100 | 7.14% |
03-25-2021 | $1.6 | $1.6 | $1.6 | $1.6 | 100 | 100 | 100% |
03-17-2021 | $1.63 | $1.59 | $1.63 | $1.54 | 1,701 | 1,601 | 94.12% |
03-05-2021 | $1.35 | $1.3 | $1.35 | $1.3 | 1,900 | 1,900 | 100% |
02-26-2021 | $1.58 | $1.46 | $1.58 | $1.46 | 1,000 | 574 | 57.4% |
01-08-2021 | $1.52 | $1.485 | $1.58 | $1.485 | 1,400 | 1,300 | 92.86% |
News, Short Squeeze, Breakout and More Instantly...
ReNeuron Group Company Name:
RNUGF Stock Symbol:
OTCMKTS Market:
(NewsDirect) ReNeuron Group PLC executive chairman Iain Ross tells Proactive that the company is focused on generating in vivo data and validating its exosome delivery technology platform CustomEX as 2023 gets underway. ReNeuron will conduct head-to-head studies with its competitors to pr...
LONDON, UK / ACCESSWIRE / October 10, 2022 / ReNeuron Group, a stem cell-derived exosome technology company, has presented encouraging preclinical data highlighting the enhanced drug delivery capability of its customisable exosome platform (CustomEx) over conventional human embryonic kidney-...
LONDON, UK / ACCESSWIRE / October 11, 2021 / ReNeuron has announced that the nine-patient Phase IIa (2m cell dose) extension study (halted in June after a presumed eye infection case) has fully restarted with five patients left to treat. Two patients are scheduled for treatment in October. T...